Myovant Sciences Company
Myovant Sciences is to deliver innovative women's health and prostate cancer solutions by efficiently advancing new medicines to market.
Connections from
Total Funding:
$200,000,000
Headquarters:
London, England, United Kingdom
Funding Status:
IPO
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Last Funding Type:
Post-IPO Debt
Last Funding Date:
2020-08-05
Investors Number:
1
Founded Date:
01-01-2016
Industry:
Menstrual Health